The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism

[1]  D. Baralle,et al.  Evidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B) , 2022, NPJ genomic medicine.

[2]  Andrew D. Yates,et al.  A compendium of uniformly processed human gene expression and splicing quantitative trait loci , 2021, Nature Genetics.

[3]  A. Chakravarti.  Magnitude of Mendelian versus complex inheritance of rare disorders , 2021, American journal of medical genetics. Part A.

[4]  G. Wong,et al.  Rare versus common diseases: a false dichotomy in precision medicine , 2021, NPJ genomic medicine.

[5]  M. Farrall,et al.  Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity , 2021, Nature Genetics.

[6]  Thomas M. Keane,et al.  Twelve years of SAMtools and BCFtools , 2020, GigaScience.

[7]  Christopher G Chute,et al.  The Human Phenotype Ontology in 2021 , 2020, Nucleic Acids Res..

[8]  Andrew J. Hill,et al.  A human cell atlas of fetal chromatin accessibility , 2020, Science.

[9]  X. Kong,et al.  [Spectrum of pathological genetic variants among 405 Chinese pedigrees affected with oculocutaneous albinism]. , 2020, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[10]  Michael J. Purcaro,et al.  Expanded encyclopaedias of DNA elements in the human and mouse genomes , 2020, Nature.

[11]  P. Stenson,et al.  The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research setting , 2020, Human Genetics.

[12]  Keith W. Muir,et al.  Whole-genome sequencing of patients with rare diseases in a national health system , 2020, Nature.

[13]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[14]  A. Hoischen,et al.  Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics , 2020, Genetics in Medicine.

[15]  Mark I. McCarthy,et al.  A brief history of human disease genetics , 2020, Nature.

[16]  Katherine R. Smith,et al.  Clinical and genetic variability in children with partial albinism , 2019, Scientific Reports.

[17]  Christopher D. Brown,et al.  The GTEx Consortium atlas of genetic regulatory effects across human tissues , 2019, Science.

[18]  W. Pavan,et al.  The Genetics of Human Skin and Hair Pigmentation. , 2019, Annual review of genomics and human genetics.

[19]  Nathan S. Abell,et al.  Genetic analyses of human fetal retinal pigment epithelium gene expression suggest ocular disease mechanisms , 2019, Communications Biology.

[20]  Bradley P. Coe,et al.  Molecular Genetic Anatomy and Risk Profile of Hirschsprung's Disease , 2019, The New England journal of medicine.

[21]  R. Guillery,et al.  Conversations with Ray Guillery on albinism: linking Siamese cat visual pathway connectivity to mouse retinal development , 2019, The European journal of neuroscience.

[22]  C. Ferreira,et al.  The burden of rare diseases , 2019, American journal of medical genetics. Part A.

[23]  Matthew W. Snyder,et al.  Genomic Medicine–Progress, Pitfalls, and Promise , 2019, Cell.

[24]  T. Rosenberg,et al.  A pathogenic haplotype, common in Europeans, causes autosomal recessive albinism and uncovers missing heritability in OCA1 , 2019, Scientific Reports.

[25]  Alexis Battle,et al.  Retinal transcriptome and eQTL analyses identify genes associated with age-related macular degeneration , 2019, Nature Genetics.

[26]  G. D. da Rocha,et al.  Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles , 2019, Scientific Reports.

[27]  P. Pennamen,et al.  Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene , 2018, British Journal of Ophthalmology.

[28]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[29]  Gregory M. Cooper,et al.  CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..

[30]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[31]  N. Schalij-Delfos,et al.  The Phenotypic Spectrum of Albinism. , 2018, Ophthalmology.

[32]  Stephane E. Castel,et al.  Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk , 2018, Nature Genetics.

[33]  Caroline F. Wright,et al.  Common genetic variants contribute to risk of rare severe neurodevelopmental disorders , 2018, Nature.

[34]  The 100 000 Genomes Project: bringing whole genome sequencing to the NHS , 2018, British Medical Journal.

[35]  D. Smedley,et al.  The 100 000 Genomes Project: bringing whole genome sequencing to the NHS , 2018, British Medical Journal.

[36]  Cristina Has,et al.  Faculty of 1000 evaluation for Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. , 2018 .

[37]  P. Pennamen,et al.  Molecular characterization of a series of 990 index patients with albinism , 2018, Pigment cell & melanoma research.

[38]  A. Philippakis,et al.  International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases , 2017, American journal of human genetics.

[39]  Birgit Sikkema-Raddatz,et al.  GAVIN: Gene-Aware Variant INterpretation for medical sequencing , 2017, Genome Biology.

[40]  R. Micura,et al.  Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain , 2017, Genome Biology.

[41]  P. Wingfield,et al.  Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity , 2017, Pigment cell & melanoma research.

[42]  E. Piozzi,et al.  Clinical evaluation and molecular screening of a large consecutive series of albino patients , 2016, Journal of Human Genetics.

[43]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[44]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[45]  G. Abecasis,et al.  Unified representation of genetic variants , 2015, Bioinform..

[46]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[47]  D. Duffy,et al.  Molecular analysis of common polymorphisms within the human Tyrosinase locus and genetic association with pigmentation traits , 2014, Pigment cell & melanoma research.

[48]  Semyon Kruglyak,et al.  Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms , 2013, Bioinform..

[49]  A. Urtti,et al.  Regulation of the human tyrosinase gene in retinal pigment epithelium cells: the significance of transcription factor orthodenticle homeobox 2 and its polymorphic binding site , 2012, Molecular vision.

[50]  M. Weale,et al.  A critical evaluation of genomic control methods for genetic association studies , 2009, Genetic epidemiology.

[51]  Wolfgang Drexler,et al.  State-of-the-art retinal optical coherence tomography , 2008, Progress in Retinal and Eye Research.

[52]  P. Donnelly,et al.  The effects of human population structure on large genetic association studies , 2004, Nature Genetics.

[53]  S. Gabriel,et al.  Assessing the impact of population stratification on genetic association studies , 2004, Nature Genetics.

[54]  M. Schemper,et al.  A solution to the problem of separation in logistic regression , 2002, Statistics in medicine.

[55]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[56]  D. Firth.  Bias reduction of maximum likelihood estimates , 1993 .

[57]  A. Garrod.  The Croonian Lectures ON INBORN ERRORS OF METABOLISM. , 1908 .

[58]  W. C. Farabee.  Notes on Negro Albinism , 1903, Science.

[59]  K. Ray,et al.  Molecular and functional studies of tyrosinase variants among Indian oculocutaneous albinism type 1 patients. , 2011, The Journal of investigative dermatology.